induce, in a concentration-dependent way, the production of both cellular and secreted U-PA antigen in primary and subcultured human endothelial cells. The TNF-induced increase was accompanied by a more than 10-fold increase in U-PA mRNA. Upon stimulation of early passage umbilical vein endothelial cells by TNF, U-PA was predominantly secreted at the basolateral side, whereas PA1 activity and NDOTHELIAL CELLS play an important role in the E regulation of fibrinolysis by the production of several key regulatory proteins; namely, the enzymes tissue-type plasminogen activator (t-PA) and urokinase-type plasminogen activator (u-PA), and their inhibitor, plasminogen activator inhibitor-1 (PAI-l).'.' In tissue sections of normal human blood vessels and in the conditioned medium of primary cultures of human umbilical vein endothelial cells, t-PA is found, but no u-PA is d e t e~t e d .~-~ Several types of cultured endothelial cells, such as bovine cell^^*^ and serially propagated human endothelial also produce u-PA. In bovine microvascular endothelial cells, the expression of u-PA activity is temporally and spatially correlated to the migration of these cells" and depends on autocrine stimulation by basic fibroblast growth factor (b-FGF). 13 The inflammatory mediators tumor necrosis factor (TNF), lymphotoxin, and interleukin-1 (IL-1) change the phenotype of endothelial cells in culture dramatically, as evidenced by changes in the immunologic properties and in the interaction with leukocytes,14 and in a shift of the hemostatic balance on the endothelial cell surface towards thrombogenicity.'5 Parallel to these events, the production of PAI-1 is while t-PA production remains u n~h a n g e d '~~~~, '~~' ' or even The shift in the balance between t-PA and PAI-1 production may impair the efficiency of the fibrinolytic process. On the other hand, besides being secreted, active PAI-1 is deposited in the extracellular matrix of endothelial ~ells.''~'~ Thus, the increase in PAI-1 production may also improve the protection of the cellular environment against uncontrolled plasminogen activator activity. Histologic studies by Kwaan and A s t r~p~~.~~ have demonstrated that during tissue repair and in experimental inflammation, plasminogen activator activity associated with the endothelium of the ingrowing capillaries is increased. The question of whether u-PA may play a role in these processes arises. Because the monokine TNF induce endothelial cell migration and neovascularisation in various experimental models,26 we investigated whether T N F and other cytokines could induce u-PA production by human endothelial cells. A t-PA were found in more equal amounts at the apical and basolateral sides of the cell monolayers. TNF-stimulated U-PA secretion by subcultured human aorta endothelial cells showed only a marginal polarity. The U-PA antigen was present in a plasmin-activatable form (single chain U-PA) and in a nonactivatable form (probably U-PA: PAL1 complex). During the induction of U-PA by TNF, the ratio between plasmin-activatable U-PA and total U-PA decreased markedly. This may indicate that TNF also increases the degree of U-PA activation. The parallel induction of the synthesis and secretion of both U-PA and PAI-1 by endothelial cells adds a new aspect to the alterations of the fibrinolytic system caused by inflammatory mediators. This aspect may be significant for the regulation of cellassociated and interstitial plasminogen activator activity. 0 1990 by The American Society of Hematology.
concomitant induction of u-PA and PAL1 might represent an additional aspect of the altered fibrinolytic properties of endothelial cells during inflammation.
MATERIALS AND METHODS
Human recombinant TNF27 and lymphotoxin (expressed in Chinese hamster ovary [CHO] cells) were gifts from Dr Jan Tavernier (Biogent, Gent, Belgium). The TNF preparation contained 2.45 x lo7 U/mg protein and less than 40 ng lipopolysaccharide (LPS) per mg protein; the specific activity of lymphotoxin was 1.6 x IO6 U/mg protein. Human recombinant interleukin-6 (expressed in yeast cells) was prepared in the Laboratory of Molecular Biology, Gent; it was biologically active and had a specific activity of 1.4 x 10' U/mg protein as tested on 7TD1 cells. Human recombinant IL-la (PI 5) and IL-lB (PI 7) were purchased from Genzyme (Haverhill, UK); polymyxin B, from Sigma (St Louis, MO). Rabbit and goat polyclonal anti-u-PA IgGs were raised in our laboratory"; donkey anti-(goat IgG) IgGs conjugated with alkaline phosphatase were purchased from Jackson ImmunoResearch Laboratories Inc (West Grove, PA). The pUK 0321 harboring a 1,023-bp fragment of the human u-PA c D N A~~ was a gift of Wolf-Dieter1992 VAN HINSBERGH ET AL characterized as previously described. Confluent cultures from umbilical artery and vein were used after three passages (split ratio, 3: 1 ), unless otherwise mentioned; confluent foreskin microvascular endothelial cells were used after 12 to 14 passages. Endothelial cell conditioned media were obtained by incubating confluent cells at 37OC for the indicated period of time in M199 medium supplemented with 10% human serum, 20 mmol/L HEPES, and penicillin/ streptomycin. In serum-free incubations, the human serum was replaced by 0.03% pyrogen-free human serum albumin. Conditioned media were immediately centrifuged and stored at -2OOC until use. After incubation, the cells were washed three times with phosphatebuffered saline and scraped in a small volume (0.5 mL/35 mm dish) of 0.5% Triton X-100 in distilled water and stored at -2OOC until use. Trasylol(20 kIU/mL) was added immediately after incubation to the samples to be used for biological immunoassay of pro-u-PA.
To determine the polarity of u-PA production, endothelial cells from umbilical vein (primary) or aorta (after five passages) were released with trypsin/EDTA and seeded in confluent density on fibronectin-coated polycarbonate filters (6 cm'; 0.4 pm pore size) in the Transwell system (Costar, Cambridge, MA). In this system, the endothelial cell monolayer separates two compartments: an upper compartment of 0.65 mL on its apical site and a lower compartment of 2.35 mL on its basolateral site. The cells were maintained under standard culture conditions and were used after 5 days. The characteristics of these monolayers have been described previously.34J5 To determine the polarity of the secretion of various proteins, the cells were incubated for 24 hours at 37OC under 5% C02/95% air atmosphere in M199 medium (without phenol red) supplemented with 10% human serum, 20 mmol/L HEPES, and penicillin/ streptomycin. The indicated amount of TNF was added to both compartments. As a control of the quality of the monolayer, horseradish peroxidase ( 5 pg/mL) was added to the upper compartment, and its passage into the lower compartment was measured.
Levels of t-PA antigen were measured by an enzyme immunoassay (Imulyse) purchased from Biopool (Umek Sweden), according to the manufacturer's description. In this assay, t-PA and t-PA:PAI-1 complexes are detected with similar efficiency.
The u-PA antigen was measured with a sandwich enzyme-linked immunosorbent assay (ELISA) essentially as described by Binnema et al,36 using donkey anti-(goat-IgG) IgGs conjugated with alkaline phosphatase instead of conjugated rabbit anti-goat IgG. The assay measures the u-PA antigen irrespective of its molecular form, ie, the inactive proenzyme single-chain u-PA (sc-u-PA), the active twochain u-PA (tc-u-PA), and the u-PA in complex with PAI-1.
The plasmin-activatable u-PA activity and active tc-u-PA activity were measured by a biological immunoassay (BIA).37 In the first step of this assay, u-PA, irrespective of its molecular form, is singled out by the same rabbit polyclonal anti-u-PA IgGs immobilized on microtiter plates as used in the u-PA antigen ELISA. In the next step, the plasminogen activator activity of the immuno-immobilized material is measured before (active tc-u-PA) and, in separate wells, after a 1-hour activation step of the immuno-immobilized material with 1 mU/mL human plasmin (active tc-u-PA plus plasminactivatable sc-u-PA). The plasminogen activator activity was assayed in a two step cascade with plasminogen and s-2251 essentially as described for t-PA3* and was read as the difference of PA activity with and without inhibitory rabbit anti-u-PA IgGs present. The plasmin-activatable u-PA in conditioned media and cell extracts of endothelial cells represents sc-u-PA, because (1) no u-PA activity was found in samples without plasmin treatment, and (2) no u-PA activity was liberated in this assay from the u-PA:PAI-l complex upon plasmin treatment. Responses in the BIA and ELISA were correlated via calibration with sc-u-PA purified from human fibroblasts, and calibration of u-PA antigen occurred as described.36 The
Assays.
lower limit of sensitivity of these assays is 0.1 ng/mL. The intraassay variation of both assays is less than 6%.
PAI-I antigen was measured by ELISA (PAI-1 ELISA kit, type FI-5) purchased from Monozyme (Charlottenlund, Denmark) according to the manufacturer's description.
PA1 activity was measured by a modification of the quantitative assay for plasminogen activator activity described by Verheijen et al.38 It was determined by titration with increasing amounts of t-PA of a fixed volume of endothelial cell-conditioned medium or control medium. The amount of PA inhibitor activity was calculated from the intersection of the asymptote of the titration curve with the X axis. In all experiments this asymptote ran parallel to the control titration curve. The curves were determined in duplicate (intra-assay variation, less than 5%). PA1 activity produced by human endothelial cells under the various experimental conditions was inhibited more than 90% by anti-PAI-1 IgG.
Cell protein was determined by the method of Lowry et al.39 Cell counts were done in duplicate by a hemocytometer.
RNA isolation and assay of u-PA and t-PA mRNA. Total RNA was isolated from cultured endothelial cells as described by Lizardi and Engelberg4' with some minor modification^.^' Gel electrophoresis, Northern blotting, and hybridization were done as previously indi~ated.~' The probes for u-PA, t-PA, PAI-1, and GAPDH were radiolabeled using a random primed DNA labeling kit (Boehringer Mannheim, Mannheim, FRG) to approximately 0.5 x lo9 cpm "P/pg DNA. The relative densities of autoradiograms (Kodak XAR5 film; Eastman Kodak Co, Rochester, NY) exposed for a suitable period were determined by densitometric scanning on a CS 910 Shimadzu scanner (Seisakusho Ltd, Kyoto, Japan) attached to a United Technology Packard data processor.
RESULTS
Induction of u-PA by inflammatory mediators. W e have previously demonstrated that TNF markedly increases the production of PAI-1 by human foreskin microvascular endothelial cells.*' These cells have a low basal rate of u-PA release, which amounts to 0.21 * 0.19 ng u-PA/lOS cells during a 24-hour incubation period. TNF stimulates the release of u-PA in a concentration-dependent way, which closely parallels the increase in the production of PA1 activity (Fig 1) . In six different cultures of microvascular endothelial cells (Table l ) , the u-PA concentration in the 24-hour conditioned medium was on average enhanced sixfold by incubation with 500 U/mL TNF. An increase in u-PA production was also observed with IL-1 and bacterial lipopolysaccharide, agents that are known also to enhance P A L 1 production. T h e TNF-induced increase in u-PA production could not be inhibited by polymyxin B (Table 1) or by anti-IL-1 antibodies (data not shown).
The induction of u-PA production was not a peculiar characteristic of microvascular endothelial cells. TNF also enhanced the production of u-PA in endothelial cells of human arteries and veins. Figure 2 shows the time course of u-PA production for two experiments with endothelial cell cultures from umbilical cord. An increase in cell-associated u-PA antigen and, subsequently, in u-PA antigen in the conditioned medium became detectable 4 to 8 hours after addition of TNF (Fig 2 A and B) . After 48 hours, the cell-associated u-PA antigen returned to the control value; the accumulation of u-PA in the medium continued for 48 to 72 hours (Fig 2 C and D) . The production of PAI-1 antigen was stimulated in a similar way by TNF (Fig 2E and F) . Considerable variation in u-PA production was observed between various cultures. The amount of u-PA in the 24-hour conditioned medium of cells treated with 500 U/mL T N F (55 * 39 ng u-PA/mL) was 15 2 11-fold higher (range, 5-to 36-fold) than that in their nontreated counterparts (4 * 2 ng u-PA/mL) (mean * S D of 14 different cultures of umbilical artery and vein endothelial cells, after two or three passages). During the same time period, the overall protein synthesis estimated by incorporation of "S-methionine did not change significantly; 24 hours after addition of 500 U/mL TNF, the overall protein synthesis was 97% * 17% of the value obtained with nonstimulated cells (mean * SD, nine cultures). The stimulation of u-PA production by T N F did not depend on the presence of serum proteins. In the 24-hour, 10% serum-containing conditioned media of three independent cultures, the basal and 500 U/mL TNF-stimulated u-PA levels were 4 f 2, and 49 * 36 ng u-PA/mL, respectively; while in their serum-free counterparts, they amounted to 5 * 2 and 60 45 ng u-PA/mL (mean SD).
The basal and increased u-PA production could be inhibited by addition of cycloheximide or actinomycin D (data not shown).
Highly confluent primary cultures of umbilical artery and vein release hardly any u-PA antigen in the supernatant medium. As is shown in Table 2 , these cells contain a small amount of u-PA associated with the cells, and they respond to T N F by a fivefold or more increase in the synthesis of u-PA antigen. An increase in u-PA antigen production was also observed when endothelial cells were incubated with lymphotoxin (Table 2) , a lymphokine that binds to the same receptor as TNF."' T N F and lymphotoxin at 500 U/mL concentrations were nearly equally effective in enhancing u-PA production by primary endothelial cell cultures.
Subcultured endothelial cells from adult human vena cava, aorta, and carotid artery vary considerably in their basal rate of u-PA production, depending upon their vascular origin and their in vitro age." Despite the large variation in basal u-PA production, the relative increase in u-PA production induced by T N F and lymphotoxin was similar to that observed with umbilical artery and vein endothelial cells (data not shown).
Total R N A isolated from untreated and TNF-stimulated endothelial cells was analyzed by Northern blotting to establish whether the increase in u-PA antigen was paralleled by an increase in the level of u-PA mRNA. Figure 3A shows the autoradiogram of a representative experiment with umbilical vein endothelial cells. The u-PA mRNA level was already elevated 2 hours after addition of 500 U/mL T N F was markedly increased after 6 and 8 hours incubation with TNF. The u-PA mRNA level declined again 24 hours after addition of TNF. A 5-to 20-fold increase in u-PA mRNA was estimated by densitometric scanning in three independent cultures of umbilical vein and artery endothelial cells that had been incubated for 6 hours with 500 U/mL TNF. The blots were rehybridized with the PAL1 mRNA probe and, as a control, with the GAPDH mRNA probe (Fig 3A) . The PAI-1 mRNA level increased continuously during incubation with T N F and became highly elevated after a 24-hour incubation period. In various experiments, the GAPDH mRNA level was not influenced by TNF. In Fig 3B it is shown that T N F also did not change the t-PA mRNA content of the cells.
To investigate whether the basal or stimulated u-PA secretion proceeds in a polarized way, we cultured human umbilical vein and aorta endothelial cells on fibronectin-coated polycarbonate filters. The cells were seeded in a very high density, and in 4 days, the cells formed a tight monolayer, the characteristics of which have been described previously in
The integrity of every Induction of u-PA mRNA by TNF.
Polarity of u-PA secretion. monolayer was verified by measuring the passage of peroxidase from the apical site towards the basolateral site of the cell monolayer. In early passage umbilical vein endothelial cells, the basal production of u-PA showed no or only a slight polarity towards the basolateral side (Fig 4) . Similarly, the production of t-PA antigen, PA1 activity, and PAI-1 antigen showed no polarity. However, after addition of 500 U/mL TNF, the increased production of u-PA was totally found at the basolateral side of the cells, whereas the increased production of PA1 activity and PAI-1 antigen was equally divided over the two compartments (Fig 4) . In human aorta endothelial cells (after six passages), the apical and basolateral secretion of u-PA antigen were 10 + 1 and 12 * 6 ng u-PA/mg cell protein, respectively, under control conditions. Although there was a preferential stimulation of the basolateral secretion as compared with the apical secretion after Highly confluent primary cultures of umbilical artery and vein endothelial cells were incubated for 24 hours in M199 medium-10% human serum with and without 500 U/mL TNF or 500 U/mL lymphotoxin. U-PA antigen was assayed by ELISA in the conditioned medium and in 0.5%
Triton X-100 cell extracts prepared after incubation. In parallel wells, cell density and protein content of the cultures was determined. addition of T N F to the cells, the polarity of the stimulated u-PA secretion was much less than in the early passage umbilical vein endothelial cells. During 24-hour stimulation with 500 U/mL TNF, the basolateral secretion was enhanced sevenfold to 85 * 13 ng u-PA/mg cell protein, whereas the increase in apical secretion was twofold less (41 * 5 ng u-PA/mg cell protein, mean * SD of three filters). Since umbilical cord endothelial cells lost their ability to form tight monolayers after two passages, we have not been able to establish whether human endothelial cells lose this polarity during subculturing. By immunoprecipitation of metabolically-labeled u-PA antigen from endothelial cellconditioned medium, we have previously d e m~n s t r a t e d "~~~ the presence of two molecular forms of u-PA: one at 55 Kd, which probably represents the sC-u-PA (pro-urokinase), and the other a t 95 Kd. The latter represents the u-PA:PAI-1 complex because it could also be precipitated by anti-PAI-1 IgG.33 Because the fluororadiograms were too faint for reliable quantification of these molecular species, we quantified sc-u-PA by BIA. To that end, u-PA was singled out from the conditioned media and cell extracts by anti-u-PA IgG fixed to microtiter wells, washed, activated with plasmin, and washed again. Finally, u-PA activity was assayed spectrophotometrically with a synthetic substrate. Without plasmin treatment, no free u-PA activity could be demonstrated in the samples, probably because the large amounts of PAI-1 in the conditioned medium and extracellular matrix of the endothelial cells irreversibly eliminated tc-u-PA. Table 3 shows that the amount of plasmin-activatable u-PA increased from 0.17 IU u-PA per well in the conditioned medium of nonstimulated cells to 1.11 IU u-PA per well in the supernatant of TNF-stimulated cells. The increase in
Plasmin activatable u-PA.
For -I -+TNF -+TNF total u-PA antigen and, hence. in nonactivatable u-PA was much higher. In the cellular extracts. the increase in u-PA antigen was found completely in the nonactivatable fraction of u-PA antigen. The plasmin-activatable u-PA represents 66% and 598. respectively. of the secreted and cellular U-PA of nonstimulated cells. whereas it was only 16% and 28% in the TNF-stimulated cells (Table 3 ). This may indicate that, together with the increase in u-PA production, a marked increase in the degree of activation occurred. A similar shift in the ratio between plasmin-activatable U-PA and total For personal use only. on June 10, 2017. by guest www.bloodjournal.org From 
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DISCUSSION
It is generally accepted that the fibrinolytic capacity of human endothelial cells is influenced by the relative production rates of t-PA and PAI-1.IS2 The cytokines TNF, lymphotoxin, and IL-1 change this capacity by increasing the production of PAI-1, while the production of t-PA remains unaffected or even decreases.'6-2' When the plasminogen activator activity in the conditioned medium of TNF-treated and untreated endothelial cells was investigated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and fibrin autography, only t-PA activity (and no u-PA activity) was detected.20i2' However, u-PA antigen has been demonstrated in the supernatant of subcultured human endothelial cells by immunoprecipitation of u-PA antigen and by ELISA.9-".33 Specifically, cells with an enlarged diameter obtained at advanced in vitro age produced considerable amounts of u-PA." We have demonstrated by assay of u-PA antigen and u-PA mRNA that T N F induces the production of u-PA by primary and subcultured human endothelial cells. The relative increase in u-PA production was similar (5-to 30-fold) in primary cultures and in early and late passage subcultured cells. This suggests that different regulatory processes underlie the increase in u-PA production induced by in vitro senescence and the inflammatory mediator TNF.
The simultaneous induction of u-PA and PAI-1 by T N F is striking. The concentration dependency of the u-PA induction by T N F is identical to that of PAI-1, and the increases in PAI-1 mRNA (Fig 4) and in PA1 activity20321 span the whole period of increased u-PA production. Activation of plasminogen by u-PA results in a broadly acting proteolytic activity; it may be a spatially controlled process (see below). The increase in PA1 activity may aim primarily to protect the endothelial cell and its environment against uncontrolled u-PA activity. A role of PAI-I in the protection against PA-dependent proteolytic degradation of the extracellular matrix has been suggested by various recent studies on endothelial cells and other cell types.21322*42343
An interesting finding was that the TNF-induced increase in u-PA production occurred in a polarized way. The u-PA was secreted mainly towards the basolateral site of stimulated umbilical vein endothelial cells. This suggests that this u-PA acts locally at the abluminal side of the endothelium, rather than in the circulation. The induction of u-PA may be of importance in the destruction of matrix proteins by the generation of plasmin and by subsequent collagenase a~t i v a t i o n .~~'~' In addition, u-PA has been suggested to play a role in cell m i g r a t i~n .~~.~' A correlation between u-PA activity and cell migration has been demonstrated in bovine adrenal capillary endothelial cells,I2 cells that show spontaneous fibrinolytic activity.'*I2 Because human artery and vein endothelial cells do not show spontaneous fibrinolytic a~t i v i t y ,~.~ a presumed action of u-PA must occur immediately upon release or activation of the plasminogen activator, or a t protected sites on the cell surface, eg, bound to the u-PA receptor. A spatially controlled action of u-PA has been suggested from several immunolocalization s t~d i e s~' .~~ and
For personal use only. on June 10, 2017. by guest www.bloodjournal.org From from the presence of a u-PA receptor on the surface of many ~e l l s ,~~~~~ including endothelial cells.55
In various experimental model^,^^.^^ T N F induces neovascularization by a process that depends on cell migration.26
The induction of u-PA in human endothelial cells by T N F reminds one of the stimulation of u-PA production by other angiogenic factors, such as b-FGF and phorbol myristate acetate (PMA), in bovine adrenal capillary endothelial ~e l l s .~~~~~~~ T N F also induces migration of bovine capillary endothelial cells in vitro26 and can induce reorganization of human endothelial cell monolayers from a cobblestone pattern into a layer of spindle-shaped cells.59 Although a role of TNF-induced u-PA production in cell shape alterations and cell migration is an attractive hypothesis, a causative relationship has not been established?8*60 Even if u-PA is involved in these processes, it is likely that the induction of u-PA is only a single violin in a whole orchestra of concertedly induced factors. The concomitant induction of u-PA and PAI-1 suggests that u-PA activity has to be tuned perfectly, and focuses attention on cell-bound and interstitial fibrinolysis in inflammation. The recent immunohistochemical demonstration of u-PA antigen in human endothelial cells of small blood vessels in inflamed appendices6' supports the in vivo relevance of our findings.
